CHN2
Beta-chimaerin
Also known as: ARHGAP3, CHIO_HUMAN, RhoGAP3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P52757
- Gene
- CHN2
- Ensembl
- ENSG00000106069
- Chromosome
- 7
- Canonical length
- 468 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that contains a phorbol-ester/diacylglycerol (DAG)-type zinc finger, a Rho-GAP domain, and an SH2 domain. The encoded protein translocates from the cytosol to the Golgi apparatus membrane upon binding by diacylglycerol (DAG). Activity of this protein is important in cell proliferation and migration, and expression changes in this gene have been detected in cancers. A mutation in this gene has also been associated with schizophrenia in men. Alternative transcript splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, May 2014]
Canonical amino-acid sequenceUniProt
468 residues, UniProt reviewed canonical sequence.
>P52757|CHN2
1 MAASSNSSLS GSSVSSDAEE YQPPIWKSYL YQLQQEAPRP KRIICPREVE NRPKYYGREF
61 HGIISREQAD ELLGGVEGAY ILRESQRQPG CYTLALRFGN QTLNYRLFHD GKHFVGEKRF
121 ESIHDLVTDG LITLYIETKA AEYISKMTTN PIYEHIGYAT LLREKVSRRL SRSKNEPRKT
181 NVTHEEHTAV EKISSLVRRA ALTHNDNHFN YEKTHNFKVH TFRGPHWCEY CANFMWGLIA
241 QGVRCSDCGL NVHKQCSKHV PNDCQPDLKR IKKVYCCDLT TLVKAHNTQR PMVVDICIRE
301 IEARGLKSEG LYRVSGFTEH IEDVKMAFDR DGEKADISAN VYPDINIITG ALKLYFRDLP
361 IPVITYDTYS KFIDAAKISN ADERLEAVHE VLMLLPPAHY ETLRYLMIHL KKVTMNEKDN
421 FMNAENLGIV FGPTLMRPPE DSTLTTLHDM RYQKLIVQIL IENEDVLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 171 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 171 nTPM
- duodenum: 72 nTPM
- small intestine: 59 nTPM
- retina: 45 nTPM
- spinal cord: 34 nTPM
- liver: 29 nTPM
Single-cell type
- tuft cells: 1,303 nCPM
- mast cells: 1,230 nCPM
- brain excitatory neurons: 738 nCPM
- cardiomyocytes: 701 nCPM
- choroid plexus epithelial cells: 680 nCPM
- pancreatic acinar cells: 632 nCPM
Immune cell
- NK-cell: 6.6 nTPM
- intermediate monocyte: 6.1 nTPM
- classical monocyte: 5.1 nTPM
- myeloid DC: 4.6 nTPM
- non-classical monocyte: 4.3 nTPM
- basophil: 3.4 nTPM
Brain region
- cerebellum: 175 nTPM
- white matter: 103 nTPM
- pons: 53 nTPM
- basal ganglia: 53 nTPM
- medulla oblongata: 49 nTPM
- hypothalamus: 43 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.13
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Rho GTPase-activating protein domain
- SH2 domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- Rho GTPase activation protein
- Chimaerin
- Diacylglycerol/phorbol-ester binding
- Chimaerin, SH2 domain
- SH2 domain superfamily
- Chimaerin, RhoGAP domain
- C1-like domain superfamily
- Rho-type GTPase-activating protein
- SH2 domain
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- RhoGAP domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CHN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHN2 as an antibody target. Whether an autoantibody or antibody against CHN2 could matter depends on whether native CHN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...